About Yael Weiss
Form D filings for Mahzi Therapeutics from 2021 to 2024 list Yael Weiss as chief executive officer and director.
Yael Weiss first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Yael Weiss in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yael Weiss works with at each company, as listed on that company's latest Form D.
Mahzi Therapeutics Inc. · Form D/A, Jul 8, 2024